p16INK4a Promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma-Reference-Cited by-同舟云学术

p16INK4a Promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma

Published:2002-10 Issue:4 Volume:123 Page:1090-1098
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Taniai Makiko,Higuchi Hajime,Burgart Lawrence J.,Gores Gregory J.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference51 articles.

1. Cholangiocarcinoma complicating primary sclerosing cholangitis;Rosen;Ann Surg,1991

2. Primary sclerosing cholangitis: liver transplantation or biliary surgery;Farges;Surgery,1995

3. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study;Bergquist;Hepatology,1998

4. Biliary tract cancers;de Groen;N Engl J Med,1999

5. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism;Jaiswal;Cancer Res,2000

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary sclerosing cholangitis and pancreatic cancer: A retrospective cohort study of United States veterans;Frontiers in Gastroenterology;2023-01-24

2. Chromosomal aberrations, visualized using UroVysion® fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients;Human Pathology;2022-08

3. Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis;World Journal of Gastrointestinal Oncology;2021-10-15

4. Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies;Scientific Reports;2021-05-20

5. Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression;Advances in Cancer Research;2021